Skip to Main Content

Paper Details

Comparing Major Bleeding Risk in Outpatients With Atrial Fibrillation or Flutter by Oral Anticoagulant Type (from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence Registry).
Am J Cardiol
13
2020
Author NameAffiliation
Thomas M MaddoxWashington University School of Medicine Healthcare Innovation Lab, BJC HealthCare/Washington University School of Medicine
Kevin F KennedyMid America Heart Institute
Richard E ShawCalifornia Pacific Medical Center
  • 1 - 3

Datasets

Release 1.2